ST Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	30,546	63,405	50,097	50,201	39,203
Short-Term Investments	-	9,518	40,000	-	44,000
Trading Asset Securities	60,444	48,001	-	-	10,013
Cash & Short-Term Investments	90,990	120,924	90,097	50,201	93,216
Cash Growth	-24.75%	34.22%	79.47%	-46.15%	-33.72%
Accounts Receivable	96,661	67,846	120,566	94,210	62,949
Other Receivables	1,768	1,972	1,500	3,131	1,499
Receivables	98,913	69,817	122,066	97,341	64,448
Inventory	169,471	126,963	120,736	107,623	80,809
Prepaid Expenses	7,738	9,120	11,901	5,818	5,039
Other Current Assets	5,555	3,254	3,577	2,251	628.76
Total Current Assets	372,668	330,078	348,378	263,234	244,142
Property, Plant & Equipment	359,334	338,695	280,105	257,885	210,190
Long-Term Investments	8,112	8,913	10,728	11,492	13,264
Goodwill	11,808	10,599	9,950	8,947	8,455
Other Intangible Assets	5,198	5,933	3,513	3,532	4,164
Long-Term Deferred Tax Assets	16,502	7,352	7,498	17,127	15,732
Other Long-Term Assets	8,522	20,305	15,264	8,436	2,619
Total Assets	782,567	721,876	675,436	570,652	498,565
Accounts Payable	11,796	10,646	17,661	18,095	12,865
Accrued Expenses	11,656	4,566	8,264	9,365	6,558
Short-Term Debt	31,042	30,000	20,878	105,854	-
Current Portion of Long-Term Debt	45,491	42,217	8,333	8,293	15,000
Current Portion of Leases	1,253	1,158	1,039	1,185	587.24
Current Income Taxes Payable	8,539	7,115	4,430	2,377	1,322
Current Unearned Revenue	5,798	6,818	2,391	-	-
Other Current Liabilities	49,176	30,761	20,748	34,054	16,243
Total Current Liabilities	164,752	133,281	83,745	179,224	52,575
Long-Term Debt	-	43,255	159,689	16,707	91,451
Long-Term Leases	929.22	1,512	2,143	2,481	479.1
Long-Term Unearned Revenue	2,552	2,738	2,791	-	956.3
Pension & Post-Retirement Benefits	604.52	766.09	584.87	-	-
Other Long-Term Liabilities	20,726	37,333	39,578	31,138	27,071
Total Liabilities	189,563	218,885	288,530	229,549	172,533
Common Stock	10,351	10,076	9,404	9,404	9,404
Additional Paid-In Capital	358,218	315,593	225,940	195,747	195,714
Retained Earnings	204,243	159,437	135,729	126,893	115,590
Comprehensive Income & Other	20,631	18,025	13,476	5,587	2,266
Total Common Equity	593,443	503,132	384,550	337,632	322,974
Minority Interest	-438.89	-141.19	2,356	3,471	3,058
Shareholders' Equity	593,004	502,991	386,906	341,103	326,033
Total Liabilities & Equity	782,567	721,876	675,436	570,652	498,565
Total Debt	78,714	118,142	192,082	134,521	107,517
Net Cash (Debt)	12,276	2,782	-101,984	-84,320	-14,301
Net Cash Growth	341.27%	-	-	-	-
Net Cash Per Share	572.43	142.64	-5422.17	-4483.00	-766.21
Filing Date Shares Outstanding	20.7	20.15	18.81	18.81	18.81
Total Common Shares Outstanding	20.7	20.15	18.81	18.81	18.81
Working Capital	207,916	196,797	264,634	84,010	191,567
Book Value Per Share	28666.39	24965.77	20445.26	17950.76	17171.46
Tangible Book Value	576,437	486,600	371,088	325,153	310,355
Tangible Book Value Per Share	27844.91	24145.44	19729.50	17287.30	16500.56
Land	60,449	60,200	60,024	59,999	52,910
Buildings	204,219	149,266	146,984	118,168	102,362
Machinery	284,708	203,768	195,642	157,855	120,141
Construction In Progress	5,282	93,149	20,794	44,421	50,144

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.